BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3119713)

  • 1. Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.
    Kumar A; Moreau JL; Gibert M; Thèze J
    J Immunol; 1987 Dec; 139(11):3680-4. PubMed ID: 3119713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
    Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
    J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for negative regulation of T cell growth by low affinity interleukin 2 receptors.
    Kumar A; Moreau JL; Baran D; Thèze J
    J Immunol; 1987 Mar; 138(5):1485-93. PubMed ID: 3100639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
    Rubin LA; Kurman CC; Fritz ME; Biddison WE; Boutin B; Yarchoan R; Nelson DL
    J Immunol; 1985 Nov; 135(5):3172-7. PubMed ID: 3930598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional characterization of artificial mutants of interleukin-2 receptor.
    Kondo S; Kinoshita M; Shimizu A; Saito Y; Konishi M; Sabe H; Honjo T
    Nature; 1987 May 7-13; 327(6117):64-7. PubMed ID: 3106825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the structure of the murine interleukin 2 (IL 2) receptor on cytotoxic and helper T cell lines by chemical cross-linking of 125I-labeled IL 2.
    Foxwell B; Taylor D; Ryffel B
    Eur J Immunol; 1988 Oct; 18(10):1515-9. PubMed ID: 2973414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain.
    Hémar A; Lieb M; Subtil A; DiSanto JP; Dautry-Varsat A
    Eur J Immunol; 1994 Sep; 24(9):1951-5. PubMed ID: 8088315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.
    Tanaka T; Saiki O; Doi S; Negoro S; Kishimoto S
    J Immunol; 1988 Jan; 140(2):470-3. PubMed ID: 2826593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.
    Kuziel WA; Ju G; Grdina TA; Greene WC
    J Immunol; 1993 Apr; 150(8 Pt 1):3357-65. PubMed ID: 8468475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
    Dukovich M; Wano Y; Le thi Bich Thuy ; Katz P; Cullen BR; Kehrl JH; Greene WC
    Nature; 1987 Jun 11-17; 327(6122):518-22. PubMed ID: 3108674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
    Audrain M; Boeffard F; Soulillou JP; Jacques Y
    J Immunol; 1991 Feb; 146(3):884-92. PubMed ID: 1988501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA; Tsudo M
    Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphorylation mediated by IL-2/IL-2 receptor beta-chain interaction.
    Ishii T; Takeshita T; Numata N; Sugamura K
    J Immunol; 1988 Jul; 141(1):174-9. PubMed ID: 3132502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    Malek TR; Robb RJ; Shevach EM
    J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.
    Rebollo A; Silva A
    Immunology; 1993 Oct; 80(2):229-35. PubMed ID: 8262551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors.
    Chu JW; Sharom FJ
    Immunology; 1993 May; 79(1):10-7. PubMed ID: 8509130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism.
    Brown M; Hu-Li J; Paul WE
    J Immunol; 1988 Jul; 141(2):504-11. PubMed ID: 3133410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The released interleukin 2 receptor binds interleukin 2 efficiently.
    Rubin LA; Jay G; Nelson DL
    J Immunol; 1986 Dec; 137(12):3841-4. PubMed ID: 3023487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.